SFTI-1 (Sunflower Trypsin Inhibitor-1)

Cyclo[Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly] is a synthetic cyclic peptide distinguished by its unique amino acid sequence and conformational stability. The cyclic structure imparts enhanced resistance to enzymatic degradation and increases its bioavailability compared to linear peptides, making it an attractive scaffold for research and development in peptide science. Its sequence, which includes arginine, cysteine, threonine, lysine, serine, isoleucine, proline, phenylalanine, aspartic acid, and glycine, allows for diverse interactions with biological targets, enabling the exploration of structure-activity relationships and functional studies. The presence of cysteine residues in cyclized form further contributes to its conformational rigidity, facilitating precise molecular recognition in experimental settings. As a result, cyclo[Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly] serves as a versatile tool in a wide array of scientific applications, supporting advancements in peptide-based research and molecular engineering.

Peptide Drug Discovery: In the context of drug discovery, cyclo[Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly] is utilized as a lead compound or template for the design of novel peptide therapeutics. Its cyclic configuration offers a promising starting point for the development of molecules with improved target selectivity and metabolic stability. Researchers often modify specific residues within the sequence to optimize binding affinity and pharmacological properties, leveraging its robust backbone to withstand physiological conditions. The peptide's resistance to proteolytic cleavage allows for prolonged activity in vitro, facilitating the identification and validation of bioactive motifs that may inform future drug candidates.

Molecular Recognition Studies: As a model system for molecular recognition, this cyclic peptide is employed in understanding protein-peptide interactions and receptor binding mechanisms. Its defined three-dimensional structure serves as an excellent mimic for natural ligands, enabling systematic analysis of binding kinetics and specificity. By incorporating site-directed mutations or chemical modifications, scientists can dissect the contributions of individual residues to overall binding efficacy, thereby elucidating the principles governing molecular recognition in biological systems. These insights are invaluable for rational drug design and the engineering of high-affinity ligands.

Bioconjugation and Diagnostic Probes: The stable cyclic framework of cyclo[Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly] makes it an ideal candidate for bioconjugation strategies aimed at developing diagnostic probes. By attaching fluorophores, radiolabels, or affinity tags to specific sites on the peptide, researchers can create highly selective imaging agents for in vitro assays or biosensor platforms. The precise spatial arrangement of functional groups within the cyclic structure enhances signal-to-noise ratios in detection systems, improving sensitivity and specificity. Additionally, the peptide's compatibility with various chemical conjugation techniques broadens its applicability in analytical and diagnostic research.

Enzyme Substrate and Inhibitor Studies: In enzymology, this cyclic peptide serves as a valuable substrate or inhibitor in the investigation of protease and peptidase activity. Its resistance to degradation by many common proteases allows for the assessment of enzyme specificity and catalytic mechanisms under controlled conditions. By monitoring the interaction between the peptide and target enzymes, researchers can identify key determinants of substrate recognition and inhibitor potency. This information supports the rational design of selective enzyme modulators and contributes to the broader understanding of proteolytic processes in biological systems.

Peptide-based Material Science: Beyond its applications in biochemistry and molecular biology, cyclo[Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly] is increasingly explored in the field of material science. Its cyclic nature and functional diversity enable the formation of self-assembled nanostructures, hydrogels, or surface coatings with tunable properties. Researchers exploit its predictable folding patterns and intermolecular interactions to engineer materials with specific mechanical, optical, or bioactive characteristics. These peptide-based materials hold promise for use in biosensing, tissue engineering, and the development of smart biomaterials with responsive functionalities. The integration of such cyclic peptides into advanced material systems exemplifies the expanding utility of peptide chemistry across interdisciplinary research domains.

1. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

2. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling